{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:25:49Z","timestamp":1789809949238,"version":"4.0.1"},"reference-count":76,"publisher":"American Society for Microbiology","issue":"22","license":[{"start":{"date-parts":[[2012,11,15]],"date-time":"2012-11-15T00:00:00Z","timestamp":1352937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Virol"],"published-print":{"date-parts":[[2012,11,15]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            We examined how well the human papillomavirus (HPV) E6 oncogene can function in the absence of the E7 oncogene during the carcinogenic process in human keratinocytes using a common HPV variant strongly associated with cervical cancer: the Asian-American E6 variant (AAE6). This E6 variant is 20 times more frequently detected in cervical cancer than the prototype European E6 variant, as evidenced by independent epidemiological data. Using cell culture and cell-based functional assays, we assessed how this variant can perform crucial carcinogenesis steps compared to the prototype E6 variant. The ability to immortalize and transform primary human foreskin keratinocytes (PHFKs) to acquire resilient phenotypes and the ability to promote cell migration were evaluated. The immortalization capability was assayed based on population doublings, number of passages, surpassing mortality stages 1 and 2, human telomerase reverse transcriptase (hTERT) expression, and the ability to overcome G\n            <jats:sub>1<\/jats:sub>\n            arrest via p53 degradation. Transformation and migration efficiency were analyzed using a combination of functional cell-based assays. We observed that either AAE6 or prototype E6 proteins alone were sufficient to immortalize PHFKs, although AAE6 was more potent in doing so. The AAE6 variant protein alone pushed PHFKs through transformation and significantly increased their migration ability over that of the E6 prototype. Our findings are in line with epidemiological data that the AA variant of HPV16 confers an increased risk over the European prototype for cervical cancer, as evidenced by a superior immortalization, transformation, and metastatic potential.\n          <\/jats:p>","DOI":"10.1128\/jvi.01512-12","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T04:41:50Z","timestamp":1346906510000},"page":"12384-12396","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":46,"title":["The Asian-American E6 Variant Protein of Human Papillomavirus 16 Alone Is Sufficient To Promote Immortalization, Transformation, and Migration of Primary Human Foreskin Keratinocytes"],"prefix":"10.1128","volume":"86","author":[{"given":"Sarah","family":"Niccoli","sequence":"first","affiliation":[{"name":"Thunder Bay Regional Research Institute, Probe Development &amp; Biomarker Exploration, Thunder Bay, Ontario, Canada"},{"name":"Lakehead University, Biology Department, Thunder Bay, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suraj","family":"Abraham","sequence":"additional","affiliation":[{"name":"Thunder Bay Regional Research Institute, Probe Development &amp; Biomarker Exploration, Thunder Bay, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Richard","sequence":"additional","affiliation":[{"name":"Lakehead University, Chemistry Department, Thunder Bay, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Zehbe","sequence":"additional","affiliation":[{"name":"Thunder Bay Regional Research Institute, Probe Development &amp; Biomarker Exploration, Thunder Bay, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/340307a0"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23881.x"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.17.1325"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.19.4.3103"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgp281"},{"key":"e_1_3_2_7_2","first-page":"7215","article-title":"Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix","volume":"63","author":"Burk RD","year":"2003","unstructured":"BurkRD. 2003. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix. Cancer Res. 63:7215\u20137220.","journal-title":"Cancer Res."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210541"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-437X(99)80014-8"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05245.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2008.06.009"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.2.1551-1563.2003"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/82.3.166"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceb.2007.02.007"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.9.5698-5705.1994"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/nprot.2006.339"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.124.4.619"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81691-8"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(85)90170-9"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.3109\/07853890109002067"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.1.473-478.1991"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1989.tb08570.x"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2009.05.036"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-006-0255-2"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.5.3710-3718.1997"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.112.24.4569"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004410050816"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9733"},{"key":"e_1_3_2_29_2","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan MB","year":"1991","unstructured":"KastanMB OnyekwereO Sidransky VogelsteinDB CraigRW. 1991. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304\u20136311.","journal-title":"Cancer Res."},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-70-5-1261"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.14.2.961-969.1994"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/380079a0"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.015"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21940"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/1750-9378-5-2"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1134\/S0026893308030084"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906357106"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00669-07"},{"key":"e_1_3_2_39_2","first-page":"6394","article-title":"Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix","volume":"61","author":"Loncaster JA","year":"2001","unstructured":"LoncasterJA. 2001. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:6394\u20136399.","journal-title":"Cancer Res."},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.15.8378-8385.2003"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.11.5698-5706.2004"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.77.18.9852-9861.2003"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/18.12.3587"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.63.10.4417-4421.1989"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.12.5559-5566.2001"},{"key":"e_1_3_2_46_2","first-page":"245","article-title":"Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy","volume":"2","author":"Pastorekov\u00e1 S","year":"2004","unstructured":"Pastorekov\u00e1S Z\u00e1vadaJ. 2004. Carbonic anhydrase IX (CA IX) as a potential target for cancer therapy. J. Cancer Ther. 2:245\u2013262.","journal-title":"J. Cancer Ther."},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.137.6.1445"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207388"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2003.10.014"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2001.0867"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.22.14.5157-5172.2002"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.93"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.65.9.4860-4866.1991"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2009.10.009"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgh296"},{"key":"e_1_3_2_56_2","first-page":"1407","article-title":"E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts","volume":"8","author":"Shay JW","year":"1993","unstructured":"ShayJW WrightWE BrasiskyteD Van der HaegenBA. 1993. E6 of human papillomavirus type 16 can overcome the M1 stage of immortalization in human mammary epithelial cells but not in human fibroblasts. Oncogene 8:1407\u20131413.","journal-title":"Oncogene"},{"key":"e_1_3_2_57_2","first-page":"1","article-title":"Defining the molecular mechanisms of human cell immortalization","volume":"1072","author":"Shay JW","year":"1991","unstructured":"ShayJW WrightWE WerbinH. 1991. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072:1\u20137.","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2006.24.18_suppl.17057"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1202053"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7600605"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0455"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.3109\/15419060009015003"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.9.4467-4472.2001"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-12-2959"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.10217"},{"key":"e_1_3_2_66_2","volume-title":"The biology of cancer","author":"Weinberg RA","year":"2007","unstructured":"WeinbergRA. 2007. The biology of cancer. Garland Science, New York, NY."},{"key":"e_1_3_2_67_2","first-page":"5370","article-title":"Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18","volume":"51","author":"Willey JC","year":"1991","unstructured":"WilleyJC. 1991. Immortalization of normal human bronchial epithelial cells by human papillomaviruses 16 or 18. Cancer Res. 51:5370\u20135377.","journal-title":"Cancer Res."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/mcb.9.7.3088-3092.1989"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1016\/0531-5565(92)90069-C"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/6010"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.11.796"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-06-0670"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.2463-2472.1997"},{"key":"e_1_3_2_74_2","first-page":"433","article-title":"Telomerase activity in normal human epithelial cells","volume":"13","author":"Yasumoto S","year":"1996","unstructured":"YasumotoS. 1996. Telomerase activity in normal human epithelial cells. Oncogene 13:433\u2013439.","journal-title":"Oncogene"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2008.09.036"},{"key":"e_1_3_2_76_2","first-page":"829","article-title":"Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype","volume":"58","author":"Zehbe I","year":"1998","unstructured":"ZehbeI WilanderE DeliusH TommasinoM. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829\u2013833.","journal-title":"Cancer Res."},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.mi.48.100194.002235"}],"container-title":["Journal of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01512-12","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JVI.01512-12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T15:17:06Z","timestamp":1646493426000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JVI.01512-12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,15]]},"references-count":76,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2012,11,15]]}},"alternative-id":["10.1128\/JVI.01512-12"],"URL":"https:\/\/doi.org\/10.1128\/jvi.01512-12","relation":{},"ISSN":["0022-538X","1098-5514"],"issn-type":[{"value":"0022-538X","type":"print"},{"value":"1098-5514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,15]]},"assertion":[{"value":"2012-06-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-08-30","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-10-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}